J Korean Med Sci.  2012 Sep;27(9):1120-1123. 10.3346/jkms.2012.27.9.1120.

Ceftiaxone-Induced Neurotoxicity: Case Report, Pharmacokinetic Considerations, and Literature Review

• Kim KB
• Kim SM
• Park W
• Kim JS
• Kwon SK
• Kim HY

• KMID: 1782150
• DOI: http://doi.org/10.3346/jkms.2012.27.9.1120

Abstract

Ceftriaxone is widely used in patients for the treatment of serious gram-negative infections. Ceftriaxone can induce some potential side effects, including neurotoxicity, however, nonconvulsive status epilepticus has rarely been reported. We report a case of acute reversible neurotoxicity associated with ceftriaxone. A 65-yr-old woman with chronic kidney disease developed altered consciousness during ceftriaxone treatment for urinary tract infection. The electroencephalogram demonstrated continuous bursts of generalized, high-voltage, 1 to 2 Hz sharp wave activity. Neurologic symptoms disappeared following withdrawal of ceftriaxone. The possibility of ceftriaxone-induced neurotoxicity should be considered in patients developing neurological impairment during ceftriaxone use, and the discontinuation of the drug could lead to complete neurological improvement.

Keyword

Ceftriaxone; Cephalosporins; Chronic Kidney Failure; Seizures

MeSH Terms

Aged
Anti-Bacterial Agents/*adverse effects/therapeutic use
Anticoagulants/therapeutic use
Ceftriaxone/*adverse effects/therapeutic use
Electroencephalography
Female
Humans
Nervous System Diseases/*etiology
Renal Dialysis
Renal Insufficiency, Chronic/pathology
Seizures/etiology
Thrombosis/diagnosis/drug therapy
Tomography, X-Ray Computed
Urinalysis
Urinary Tract Infections/diagnosis/drug therapy
Anti-Bacterial Agents
Anticoagulants
Ceftriaxone

Figure

• 

  Fig. 1 Electroencephalogram (EEG) findings during nonconvulsive status epilepticus and recovery state. (A) EEG on day 22, when the patient presented an altered mental state. An EEG showed generalized slowing of the background with superimposed almost continuous bursts of generalized, moderate to high amplitude that had an almost periodic pattern (arrows). (B) EEG on day 24, when the patient's neurologic symptoms resolved completely. Epileptiform discharges had disappeared.

• 

  Fig. 2 Abdomen/Pevis CT showing the extensive thrombosis (arrowheads). (A) Thrombosis in the inferior vena cava. (B) Thrombosis in the renal vein.

Reference

1. Rockowitz J, Tunkel AR. Bacterial meningitis. Practical guidelines for management. Drugs. 1995. 50:838–853.

2. Weisfelt M, de Gans J, van de Beek D. Bacterial meningitis: a review of effective pharmacotherapy. Expert Opin Pharmacother. 2007. 8:1493–1504.

3. Patel IH, Sugihara JG, Weinfeld RE, Wong EG, Siemsen AW, Berman SJ. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Antimicrob Agents Chemother. 1984. 25:438–442.

4. Martinez-Rodriguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, dela Rosa CR. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med. 2001. 111:115–119.

5. Sato Y, Morita H, Wakasugi H, Iijima S, Kawashima E, Wakayama Y, Yoshimura A. Reversible chreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease. Am J Med Sci. 2010. 340:382–384.

6. Roncon-Albuquerque R Jr, Pires I, Martins R, Real R, Sousa G, von Hafe P. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection. Neth J Med. 2009. 67:72–75.

7. Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Ann Pharmacother. 2008. 42:1843–1850.

8. Lam S, Gomolin IH. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review. Pharmacotherapy. 2006. 26:1169–1174.

9. Kim SY, Lee IS, Park SL, Lee J. Cefepime neurotoxicity in patients with renal insufficiency. Ann Rehabil Med. 2012. 36:159–162.

10. Johnson H, Walker A. Intraventricular penicillin: a note of warning. JAMA. 1945. 127:217–219.

11. De Sarro A, Ammendola D, Zappala M, Grasso S, De Sarro GB. Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob Agents Chemother. 1995. 39:232–237.

12. Wallace KL. Antibiotics-induced convulsions. Crit Care Clin. 1997. 13:741–762.

13. Alkharfy KM, Kellum JA, Frye RF, Matzke GR. Effect of ceftazidime on systemic cytokine concentrations in rats. Antimicrob Agents Chemother. 2000. 44:3217–3219.

14. Schliamser SE, Cars O, Norrby R. Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother. 1991. 27:405–425.

15. Calandra G, Lydick E, Carrigan J, Weiss L, Guess H. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. Am J Med. 1988. 84:911–918.

16. Cohen D, Appel GB, Scully B, Neu HC. Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis. Antimicrob Agents Chemother. 1983. 24:529–532.